CNBX Pharmaceuticals Inc.

CNBX · OTC · SIC 2834: Pharmaceutical Preparations
175
SEC Filings

Business Summary

CNBX Pharmaceuticals Inc. is a clinical-stage company based in Bethesda, Maryland, focused on the discovery, development, and commercialization of novel cannabinoid-based products for cancer treatment. Its lead product, Cannabics SR, is an oral sustained-release capsule for cancer anorexia cachexia syndrome (CACS). Its second candidate, RCC-33, is a first-in-class anti-neoplastic drug for colorectal cancer. R&D is conducted in a government-licensed lab in Israel through its wholly owned subsidiary G.R.I.N Ultra Ltd.

Next Earnings

Q2 FY2026 — expected 2026-07-12

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionCNBXdiscussed_in_filing Cybersecurity
topic_mentionCNBXdiscussed_in_filing Trusted Computing
topic_mentionCNBXdiscussed_in_filing Blockchain & Crypto
topic_mentionCNBXdiscussed_in_filing Regulation
topic_mentionCNBXdiscussed_in_filing Healthcare & Bio
topic_mentionCNBXdiscussed_in_filing Platform & Ecosystem
topic_mentionCNBXdiscussed_in_filing Sovereign & Government
topic_mentionCNBXdiscussed_in_filing Cybersecurity
topic_mentionCNBXdiscussed_in_filing Trusted Computing
topic_mentionCNBXdiscussed_in_filing Blockchain & Crypto
topic_mentionCNBXdiscussed_in_filing Regulation
topic_mentionCNBXdiscussed_in_filing Healthcare & Bio
topic_mentionCNBXdiscussed_in_filing Platform & Ecosystem
topic_mentionCNBXdiscussed_in_filing Sovereign & Government
topic_mentionCNBXdiscussed_in_filing Cybersecurity
topic_mentionCNBXdiscussed_in_filing Trusted Computing
topic_mentionCNBXdiscussed_in_filing Blockchain & Crypto
topic_mentionCNBXdiscussed_in_filing Regulation
topic_mentionCNBXdiscussed_in_filing Healthcare & Bio
topic_mentionCNBXdiscussed_in_filing Platform & Ecosystem

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2025-12-012025-08-310001683168-25-008736EDGAR45K words
2024-11-292024-08-310001683168-24-008433EDGAR—
2023-11-302023-08-310001683168-23-008557EDGAR—
2022-11-302022-08-310001683168-22-008095EDGAR—
2021-11-292021-08-310001683168-21-006005EDGAR—
2020-11-042020-08-310001683168-20-003686EDGAR—
2019-11-292019-08-310001683168-19-003852EDGAR—
2018-11-292018-08-310001683168-18-003584EDGAR—
2017-12-082017-08-310001683168-17-003260EDGAR—
2016-12-132016-08-310001683168-16-000925EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-01-142025-11-300001683168-26-000285EDGAR9K words
2025-07-142025-05-310001683168-25-005075EDGAR—
2025-04-142025-02-280001683168-25-002511EDGAR—
2025-01-132024-11-300001683168-25-000267EDGAR—
2024-07-152024-05-310001683168-24-004831EDGAR—
2024-04-162024-02-290001683168-24-002440EDGAR—
2024-01-122023-11-300001683168-24-000255EDGAR—
2023-07-142023-05-310001683168-23-004890EDGAR—
2023-04-142023-02-280001683168-23-002379EDGAR—
2023-01-132022-11-300001683168-23-000174EDGAR—
2022-07-142022-05-310001683168-22-004948EDGAR—
2022-04-122022-02-280001683168-22-002526EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-170001683168-26-001883EDGAR1K words
2025-01-300001683168-25-000583EDGAR—
2024-03-220001683168-24-001610EDGAR—
2023-02-080001683168-23-000628EDGAR—
2022-12-290001683168-22-008672EDGAR—
2022-07-250001683168-22-005100EDGAR—
2022-05-130001683168-22-003584EDGAR—
2022-03-280001683168-22-001999EDGAR—
2022-03-160001683168-22-001701EDGAR—
2022-02-170001683168-22-001084EDGAR—

175 total filings indexed. 143 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Tags

oncology cancer-anorexia-cachexia-syndrome-(cacs) colorectal-cancer cannabinoid-based-pharmaceuticals

Company Identity

CIK0001343009
TickerCNBX
ExchangeOTC
SIC2834: Pharmaceutical Preparations
IncorporatedNV
HeadquartersBethesda, Maryland

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: e23f0a6b070b39e90058222c056749b62e88ee46a9412c8d2c8746a9c2343f5e
parent: e622e05a6a9428a916d676912ab43732face3a9838218a674cd37c64e4ee64b7
content hash: 768ab329b0011292ea0f6d7a9838fbaae4d680cb921ee47940ded50ad8fbc30f
signed: 2026-04-13T04:44:24.077Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf